There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (1)

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To ensure access to affordable, comprehensive health insurance benefits for certain uninsured individuals during the COVID-19 emergency, and to ensure adequate coverage of treatments for COVID-19 under the Medicare and Medicaid programs and under group health plans and group or individual health insurance coverage, and for other purposes.


Actions Overview (1)

Date Actions Overview
05/01/2020Introduced in House

All Actions (5)

Date All Actions
05/01/2020Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Labor, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
05/01/2020Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Labor, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
05/01/2020Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Labor, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
05/01/2020Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Labor, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
05/01/2020Introduced in House
Action By: House of Representatives

Cosponsors (45)

* = Original cosponsor
CosponsorDate Cosponsored
Rep. Kennedy, Joseph P., III [D-MA-4]* 05/01/2020
Rep. Blumenauer, Earl [D-OR-3]* 05/01/2020
Rep. Clarke, Yvette D. [D-NY-9]* 05/01/2020
Rep. Cohen, Steve [D-TN-9]* 05/01/2020
Rep. Dingell, Debbie [D-MI-12]* 05/01/2020
Rep. Doyle, Michael F. [D-PA-18]* 05/01/2020
Rep. Espaillat, Adriano [D-NY-13]* 05/01/2020
Rep. Hastings, Alcee L. [D-FL-20]* 05/01/2020
Rep. Hayes, Jahana [D-CT-5]* 05/01/2020
Rep. Jackson Lee, Sheila [D-TX-18]* 05/01/2020
Rep. Khanna, Ro [D-CA-17]* 05/01/2020
Rep. Lee, Barbara [D-CA-13]* 05/01/2020
Rep. Lowenthal, Alan S. [D-CA-47]* 05/01/2020
Rep. McGovern, James P. [D-MA-2]* 05/01/2020
Rep. Meng, Grace [D-NY-6]* 05/01/2020
Rep. Napolitano, Grace F. [D-CA-32]* 05/01/2020
Rep. Neguse, Joe [D-CO-2]* 05/01/2020
Rep. Norton, Eleanor Holmes [D-DC-At Large]* 05/01/2020
Rep. Ocasio-Cortez, Alexandria [D-NY-14]* 05/01/2020
Rep. Omar, Ilhan [D-MN-5]* 05/01/2020
Rep. Pingree, Chellie [D-ME-1]* 05/01/2020
Rep. Pressley, Ayanna [D-MA-7]* 05/01/2020
Rep. Raskin, Jamie [D-MD-8]* 05/01/2020
Rep. Schakowsky, Janice D. [D-IL-9]* 05/01/2020
Rep. Soto, Darren [D-FL-9]* 05/01/2020
Rep. Takano, Mark [D-CA-41]* 05/01/2020
Rep. Tlaib, Rashida [D-MI-13]* 05/01/2020
Rep. Vargas, Juan [D-CA-51]* 05/01/2020
Rep. Welch, Peter [D-VT-At Large]* 05/01/2020
Rep. Gabbard, Tulsi [D-HI-2]* 05/01/2020
Rep. Engel, Eliot L. [D-NY-16]* 05/01/2020
Rep. Velazquez, Nydia M. [D-NY-7]* 05/01/2020
Rep. DeFazio, Peter A. [D-OR-4] 05/12/2020
Rep. Scanlon, Mary Gay [D-PA-5] 05/12/2020
Rep. Pocan, Mark [D-WI-2] 05/12/2020
Rep. Garcia, Jesus G. "Chuy" [D-IL-4] 05/12/2020
Rep. Brown, Anthony G. [D-MD-4] 06/11/2020
Rep. Adams, Alma S. [D-NC-12] 06/11/2020
Rep. Gallego, Ruben [D-AZ-7] 06/11/2020
Rep. Boyle, Brendan F. [D-PA-2] 06/11/2020
Rep. Sarbanes, John P. [D-MD-3] 06/11/2020
Rep. Rush, Bobby L. [D-IL-1] 06/22/2020
Rep. Thompson, Mike [D-CA-5] 06/24/2020
Rep. Cicilline, David N. [D-RI-1] 07/21/2020
Rep. Davis, Danny K. [D-IL-7] 09/01/2020

Committees (4)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce05/01/2020 Referred to
House Ways and Means05/01/2020 Referred to
House Education and Labor05/01/2020 Referred to
House Armed Services05/01/2020 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.


Latest Summary (1)

There is one summary for H.R.6674. View summaries

Shown Here:
Introduced in House (05/01/2020)

Medicare Crisis Program Act of 2020

This bill makes a series of changes to health insurance coverage and requirements during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019).

For example, the bill makes several changes to Medicare and Medicare Advantage (MA) during the public health emergency. Among other things, the bill

  • allows all individuals who receive unemployment benefits, and their dependents, to enroll in Medicare if they otherwise do not have health insurance coverage;
  • eliminates cost-sharing for COVID-19 drugs and treatment services under Medicare and MA;
  • eliminates premiums under Medicare and caps overall cost-sharing under Medicare and MA; and
  • establishes a national clearinghouse for the purchase and distribution of COVID-19 personal protective equipment for Medicare providers.

The bill also alters requirements under Medicaid and the Children's Health Insurance Program (CHIP) and for private health insurers during the emergency. Among other things, the bill

  • requires coverage of COVID-19 vaccines and treatment services under Medicaid and CHIP without cost-sharing;
  • increases the Medicaid Federal Medical Assistance Percentage (FMAP) that is otherwise applicable during the public health emergency, including for states experiencing economic downturns (i.e., high unemployment);
  • requires private health insurers to cover COVID-19 treatment services without cost-sharing; and
  • requires federal payment to health care providers for the cost of COVID-19 treatment services that are provided to uninsured individuals, based on Medicare payment rates.